# Enhanced Drug Distribution Security Requirements Under Section 582(g)(1) of the Federal Food, Drug, and Cosmetic Act--Compliance Policies - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/enhanced-drug-distribution-security-requirements-under-section-582g1-of-the-federal-food-drug-and-cosmetic-act-compliance-policies/81e414c7-4ee9-4a96-aba3-257bbafce4bd

> FDA guidance document: Enhanced Drug Distribution Security Requirements Under Section 582(g)(1) of the Federal Food, Drug, and Cosmetic Act--Compliance Policies. Issue date: August 28, 2023. Get complete insights and analysis.

---

## Details

- Title: Enhanced Drug Distribution Security Requirements Under Section 582(g)(1) of the Federal Food, Drug, and Cosmetic Act--Compliance Policies
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2023-08-28
- Last Changed: 2024-11-05
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2023-D-1909">FDA-2023-D-1909</a>

## Related Documents

- [Requirements for Transactions with First Responders under Section 582 of the Federal Food, Drug, and Cosmetic Act— Compliance Policy Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/requirements-for-transactions-with-first-responders-under-section-582-of-the-federal-food-drug-and-cosmetic-act-compliance-policy-guidance-for-industry/46d7c1a7-9368-4929-afbd-858d5ebfae9f)
- [Exemption and Exclusion From Certain Requirements of the Drug Supply Chain Security Act for the Distribution of FDA-Approved Naloxone Products During the Opioid Public Health Emergency Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/exemption-and-exclusion-from-certain-requirements-of-the-drug-supply-chain-security-act-for-the-distribution-of-fda-approved-naloxone-products-during-the-opioid-public-health-emergency-guidance-for-industry/d210019a-9b7e-4dde-8567-15304071541d)
- [COVID-19: Developing Drugs and Biological Products for Treatment or Prevention:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/covid-19-developing-drugs-and-biological-products-for-treatment-or-prevention-guidance-for-industry/a6c3249b-9395-4d0b-96dd-986a992b4139)